Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Adenocarcinoma × regorafenib × Clear all

Phase

Status

Unknown 1 Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Colorectal Neoplasms 13 Carcinoma, Hepatocellular 7 Neoplasm Metastasis 2 Melanoma 2 Advanced Colorectal Cancer 2 Turcot syndrome 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Tertiary Lymphoid Structures 1 TAS 102 1 Stomach Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Mesothelioma, Malignant 1 Gastrointestinal Stromal Tumors 1 Gastro-enteropancreatic neuroendocrine tumor 1 Fatigue 1 Colorectal Cancer Metastatic 1 Colorectal Cancer Liver Metastases 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Biliary Tract Neoplasms 1 Asian Colorectal Cancer Patients 1 Advanced Colorectal Carcinoma 1 Advanced Biliary Systemic Tumours That Has Failed at Least One Prior Systemic Therapy 1 Adenocarcinoma 1

Interventions

Capecitabine 5 Pemetrexed 4 Docetaxel 4 pembrolizumab 2 icotinib 2 Oxaliplatin 2 Gemcitabine 2 Gefitinib 2 Drug Therapy 2 Chemoradiotherapy 2 sintilimab 1 rucaparib 1 regorafenib 1 lenvatinib 1 iron isomaltoside 1000 1 ipatasertib 1 iopromide 1 gluconic acid 1 atezolizumab 1 anlotinib 1 XELOX 1 Trastuzumab 1 Telemedicine 1 Surveys and Questionnaires 1 Sorafenib 1 S 1 (combination) 1 Registries 1 Ramucirumab 1 Radiotherapy 1 Radiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02773524 2022-01-13

INTEGRATEIIa

Australasian Gastro-Intestinal Trials Group

Phase 3 Unknown

Adenocarcinoma, Carcinoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡